Amyloid fibril formation by pulmonary surfactant protein C

被引:94
|
作者
Gustafsson, M
Thyberg, J
Näslund, J
Eliasson, E
Johansson, J [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Neurosci, S-14186 Huddinge, Sweden
[4] Karolinska Inst, Dept Environm Med, S-17177 Stockholm, Sweden
关键词
amyloid fibril; lipid-associated peptide; protein palmitoylation; pulmonary surfactant; surfactant protein C;
D O I
10.1016/S0014-5793(99)01692-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lung surfactant protein C (SP-C) is a lipopeptide that contains two fatty acyl (palmitoyl) chains bound via intrinsically labile thioester bonds, SP-C can transform from a monomeric alpha-helix into beta-sheet aggregates, reminiscent of structural changes that are supposed to occur in amyloid fibril formation, SP-C is here shown to form amyloid upon incubation in solution. Furthermore, one patient with pulmonary alveolar proteinosis (PAP, a rare disease where lung surfactant proteins and lipids accumulate in the airspaces) and six healthy controls have been studied regarding presence and composition of amyloid fibrils in the cell-free fraction of bronchoalveolar lavage (BAL) fluid. Abundant amyloid fibrils were found in BAL fluid from the patient with PAP and, in low amounts, in three of the six healthy controls. SDS-insoluble fibrillar material associated with PAP mainly consists of SP-C, in contrast to the fibrils found in controls. Fibrillated SP-C has to a significant extent lost the palmitoyl groups, and removal of the palmitoyl groups in vitro increases the rate of fibril formation, (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 50 条
  • [1] Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C
    Johansson, J
    [J]. SWISS MEDICAL WEEKLY, 2003, 133 (19-20) : 275 - 282
  • [2] Membrane properties and amyloid fibril formation of lung surfactant protein
    Johansson, J
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2001, 29 : 601 - 606
  • [3] Protein folding aspects of amyloid fibril formation
    Fändrich, M
    Dobson, CM
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 26 - 26
  • [4] Amyloid fibril formation by bovine cytochrome c
    de Groot, NS
    Ventura, S
    [J]. SPECTROSCOPY-AN INTERNATIONAL JOURNAL, 2005, 19 (04): : 199 - 205
  • [5] Biophysical Studies on Protein Aggregation and Amyloid Fibril Formation
    Bhattacharya, Mily
    Jain, Neha
    Dogra, Priyanka
    Samai, Soumyadyuti
    Patil, Smita
    Mukhopadhyay, Samrat
    [J]. BIOPHYSICAL JOURNAL, 2012, 102 (03) : 443A - 443A
  • [6] AMYLOID FIBRIL FORMATION
    COLACO, CALS
    HARRINGTON, CR
    [J]. BIO-TECHNOLOGY, 1994, 12 (09): : 848 - 849
  • [7] Amyloid fibril formation from crude protein mixtures
    Rao, Shiva P.
    Meade, Susie J.
    Joyce, Nigel I.
    Healy, Jackie P.
    Sutton, Kevin H.
    Larsen, Nigel G.
    Gerrard, Juliet A.
    [J]. BIOTECHNOLOGY PROGRESS, 2011, 27 (06) : 1768 - 1776
  • [8] Binding of cystatin C to amyloid beta inhibits amyloid fibril formation
    Pawlik, M
    Sastre, M
    Calero, M
    Mathews, PM
    Kumar, A
    Schmidt, SD
    Nixon, RA
    Levy, E
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S241 - S241
  • [9] Inhibiting transthyretin amyloid fibril formation via protein stabilization
    Miroy, GJ
    Lai, ZH
    Lashuel, HA
    Peterson, SA
    Strang, C
    Kelly, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) : 15051 - 15056
  • [10] Crosstalk between tau protein autoproteolysis and amyloid fibril formation
    Ashrafi-Kooshk, Mohammad Reza
    Norouzi, Fatemeh
    Karizak, Ashkan Zare
    Ahmadian, Shahin
    Moosavi-Movahedi, Ali Akbar
    Riazi, Gholamhossein
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 262